fda approves first oral glp-1 obesity drug august 1 2025 Wegovy pill for weight loss approved by FDA; 1st of its kind Novo Nordisk launches its Wegovy

Ginger, either as fresh ginger tea, ginger ale (with real ginger), or ginger supplements (typically 250 mg four times daily), has demonstrated antiemetic properties in clinical studies for various types of nausea, though evidence specific to GLP-1 medications is limited

Liraglutide and exenatide are already off-patent and semaglutide will begin losing exclusivity in several large countries from 2026 (read more in our blog Off-patent semaglutide in 2026)

GiuglianoDLongoMSignorielloSMaiorinoMISolerteBChiodiniPet alThe effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

Josephson, A

How should I store retatrutide from Simple Peptide

author reply 9